$CNO
CNO Financial Group, Inc. Stock $cno

$cno Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000122460820000019 Filed on May 11, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$717.2M	$1.023B
YoY Change	-29.89%	1.51%
Cost Of Revenue	$490.8M	$623.5M
YoY Change	-21.28%	6.29%
Gross Profit	$226.4M	$399.5M
YoY Change	-43.33%	-5.15%
Gross Profit Margin	31.57%	39.05%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$59.60M	$66.60M
YoY Change	-10.51%	-15.37%
% of Gross Profit	26.33%	16.67%
Operating Expenses	$754.8M	$916.4M
YoY Change	-17.63%	5.81%
Operating Profit	$105.5M	$83.40M
YoY Change	26.5%	-12.12%
Interest Expense	$33.40M	$41.00M
YoY Change	-18.54%	22.02%
% of Operating Profit	31.66%	49.16%
Other Income/Expense, Net
YoY Change
Pretax Income	-$71.00M	$65.60M
YoY Change	-208.23%	-39.32%
Income Tax	-$49.80M	$13.80M
% Of Pretax Income		21.04%
Net Earnings	-$21.20M	$51.80M
YoY Change	-140.93%	-38.55%
Net Earnings / Revenue	-2.96%	5.06%
Basic Earnings Per Share	-$0.15	$0.32
Diluted Earnings Per Share	-$0.15	$0.32
COMMON SHARES
Basic Shares Outstanding	145.8M shares	160.9M shares
Diluted Shares Outstanding	145.8M shares	162.2M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$550.5M	$691.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$64.00M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$24.26B	$23.68B
YoY Change	2.44%	-13.63%
Other Assets	$703.0M	$480.0M
YoY Change	46.46%	6.67%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$33.61B	$31.44B
YoY Change	6.92%	-4.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$3.786B	$3.980B
YoY Change	-4.87%	0.2%
Other Long-Term Liabilities	$851.0M	$804.0M
YoY Change	5.85%	-7.48%
Total Long-Term Liabilities	$4.637B	$4.784B
YoY Change	-3.07%	-1.18%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities	$4.637B	$4.784B
Total Liabilities	$28.97B	$28.48B
YoY Change	1.73%	1.01%
SHAREHOLDERS EQUITY
Retained Earnings	$517.9M	$193.5M
YoY Change	167.65%	-66.45%
Common Stock	$2.690B	$2.954B
YoY Change	-8.93%	-4.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.659B	$3.368B
YoY Change
Total Liabilities & Shareholders Equity	$32.74B	$32.31B
YoY Change	1.3%	-1.51%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$21.20M	$51.80M
YoY Change	-140.93%	-38.55%
Depreciation, Depletion And Amortization	$59.60M	$66.60M
YoY Change	-10.51%	-15.37%
Cash From Operating Activities	$125.7M	$142.3M
YoY Change	-11.67%	97.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$7.300M	$10.60M
YoY Change	-31.13%	39.47%
Cash From Investing Activities	-$178.2M	-$126.1M
YoY Change	41.32%	28.54%
FINANCING ACTIVITIES
Cash Dividend Paid	$16.20M	$16.40M
YoY Change	-1.22%	6.49%
Common Stock Issuance & Retirement, Net	$85.30M	$41.20M
YoY Change	107.04%	795.65%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$51.70M	$18.50M
YoY Change	-379.46%	-470.0%
NET CHANGE
Cash From Operating Activities	$125.7M	$142.3M
Cash From Investing Activities	-$178.2M	-$126.1M
Cash From Financing Activities	-$51.70M	$18.50M
Net Change In Cash	-$104.2M	$34.70M
YoY Change	-400.29%	-212.3%
FREE CASH FLOW
Cash From Operating Activities	$125.7M	$142.3M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2020Q1	cno	Investments Held By Variable Interest Entities Allowance For Credit Loss InvestmentsHeldByVariableInterestEntitiesAllowanceForCreditLoss	37700000	USD
CY2019Q4	cno	Investments Held By Variable Interest Entities Amortized Cost InvestmentsHeldByVariableInterestEntitiesAmortizedCost	1206300000	USD
CY2020Q1	cno	Investments Held By Variable Interest Entities Amortized Cost InvestmentsHeldByVariableInterestEntitiesAmortizedCost	1216400000	USD
CY2019Q1	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale Tax NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSaleTax	100000	USD
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	148084178	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	143610046	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	148084178	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	143610046	shares
CY2019Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	44200000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	65900000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	132300000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-214100000	USD
CY2020Q1	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	4000000	USD
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	dei	Entity File Number EntityFileNumber	001-31792
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	CNO Financial Group, Inc.
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-3108137
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	11825 N. Pennsylvania Street
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Carmel,
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46032
CY2020Q1	dei	City Area Code CityAreaCode	(317)
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	817-6100
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	143617498	shares
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	20379100000	USD
CY2019Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21295200000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	50100000	USD
CY2019Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	44100000	USD
CY2020Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1484100000	USD
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1566100000	USD
CY2020Q1	us-gaap	Policy Loans Receivable PolicyLoansReceivable	124700000	USD
CY2019Q4	us-gaap	Policy Loans Receivable PolicyLoansReceivable	124500000	USD
CY2020Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	227800000	USD
CY2019Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	243900000	USD
CY2020Q1	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1038100000	USD
CY2019Q4	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1188600000	USD
CY2020Q1	us-gaap	Other Investments OtherInvestments	953300000	USD
CY2019Q4	us-gaap	Other Investments OtherInvestments	1118500000	USD
CY2020Q1	cno	Number Of Product Distribution Channels NumberOfProductDistributionChannels	3	distribution_channel
CY2020Q1	us-gaap	Investments Investments	24257200000	USD
CY2019Q4	us-gaap	Investments Investments	25580900000	USD
CY2020Q1	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	482000000.0	USD
CY2019Q4	cno	Cash And Cash Equivalents At Carrying Value Excluding Variable Interest Entities CashAndCashEquivalentsAtCarryingValueExcludingVariableInterestEntities	580000000.0	USD
CY2020Q1	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	68500000	USD
CY2019Q4	cno	Cash And Cash Equivalents Held By Variable Interest Entities CashAndCashEquivalentsHeldByVariableInterestEntities	74700000	USD
CY2020Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	213000000.0	USD
CY2019Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	205900000	USD
CY2020Q1	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	282200000	USD
CY2019Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	275400000	USD
CY2020Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1398600000	USD
CY2019Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	1215500000	USD
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001224608
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Policyholder Funds PolicyholderFunds	12138100000	USD
CY2019Q4	us-gaap	Policyholder Funds PolicyholderFunds	12132300000	USD
CY2020Q1	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11429900000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	USD
CY2019Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	11498500000	USD
CY2020Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	510700000	USD
CY2019Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	522300000	USD
CY2020Q1	us-gaap	Unearned Premiums UnearnedPremiums	251000000.0	USD
CY2019Q4	us-gaap	Unearned Premiums UnearnedPremiums	260500000	USD
CY2020Q1	us-gaap	Separate Accounts Liability SeparateAccountsLiability	3200000	USD
CY2019Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	4200000	USD
CY2020Q1	us-gaap	Notes Payable NotesPayable	989400000	USD
CY2019Q4	us-gaap	Notes Payable NotesPayable	989100000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	28969200000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	28953900000	USD
CY2020Q1	us-gaap	Other Liabilities OtherLiabilities	850700000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	750200000	USD
CY2020Q1	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4727500000	USD
CY2019Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4785700000	USD
CY2020Q1	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	703200000	USD
CY2019Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	432600000	USD
CY2020Q1	us-gaap	Separate Account Assets SeparateAccountAssets	3200000	USD
CY2019Q4	us-gaap	Separate Account Assets SeparateAccountAssets	4200000	USD
CY2020Q1	us-gaap	Other Assets OtherAssets	599600000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	476000000.0	USD
CY2020Q1	us-gaap	Assets Assets	32735000000.0	USD
CY2019Q4	us-gaap	Assets Assets	33630900000	USD
CY2020Q1	cno	Investment Borrowings InvestmentBorrowings	1643900000	USD
CY2019Q4	cno	Investment Borrowings InvestmentBorrowings	1644300000	USD
CY2020Q1	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1152300000	USD
CY2019Q4	cno	Borrowings Related To Variable Interest Entities BorrowingsRelatedToVariableInterestEntities	1152500000	USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	1400000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	1500000	USD
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2688500000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-21200000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	51800000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145829000	shares
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2767300000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	595200000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1372500000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	480700000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	535700000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	3765800000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4677000000.0	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32735000000.0	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33630900000	USD
CY2020Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	628700000	USD
CY2019Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	619300000	USD
CY2020Q1	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	280300000	USD
CY2019Q1	cno	Net Investment Income On General Account Invested Assets NetInvestmentIncomeOnGeneralAccountInvestedAssets	268800000	USD
CY2020Q1	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	-110700000	USD
CY2019Q1	cno	Net Investment Income On Policyholder And Reinsurer Accounts And Other Special Purpose Portfolios NetInvestmentIncomeOnPolicyholderAndReinsurerAccountsAndOtherSpecialPurposePortfolios	87000000.0	USD
CY2020Q1	us-gaap	Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss	-60100000	USD
CY2019Q1	us-gaap	Debt And Equity Securities Gain Loss Excluding Other Than Temporary Impairment Loss DebtAndEquitySecuritiesGainLossExcludingOtherThanTemporaryImpairmentLoss	18300000	USD
CY2020Q1	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-55400000	USD
CY2019Q1	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-2200000	USD
CY2020Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-115500000	USD
CY2019Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	16100000	USD
CY2020Q1	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	34400000	USD
CY2019Q1	cno	Fee Revenue And Other Income FeeRevenueAndOtherIncome	31800000	USD
CY2020Q1	us-gaap	Revenues Revenues	717200000	USD
CY2019Q1	us-gaap	Revenues Revenues	1023000000.0	USD
CY2020Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	490800000	USD
CY2019Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	623500000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	33400000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	41000000.0	USD
CY2020Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	50200000	USD
CY2019Q1	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	58200000	USD
CY2020Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	213800000	USD
CY2019Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	234700000	USD
CY2020Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	788200000	USD
CY2019Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	957400000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-71000000.0	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	65600000	USD
CY2020Q1	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	-15800000	USD
CY2019Q1	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	13800000	USD
CY2020Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-34000000.0	USD
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	160948000	shares
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	3765800000	USD
CY2020Q1	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	575300000	USD
CY2019Q1	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	581200000	USD
CY2020Q1	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	285700000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	USD
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145829000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	162189000	shares
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-21200000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	51800000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1325400000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	690200000	USD
CY2020Q1	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	-136300000	USD
CY2019Q1	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisition Costs Unrealized Holding Gain Loss Arising During Periodbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionCostsUnrealizedHoldingGainLossArisingDuringPeriodbeforeTax	50500000	USD
CY2020Q1	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	135500000	USD
CY2019Q1	cno	Other Comprehensive Income Loss Amortizationof Present Valueof Future Profitsand Deferred Acquisitions Costs Reductionin Premium Deficienciesbefore Tax OtherComprehensiveIncomeLossAmortizationofPresentValueofFutureProfitsandDeferredAcquisitionsCostsReductioninPremiumDeficienciesbeforeTax	-31500000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-65600000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-1100000	USD
CY2020Q1	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	-3400000	USD
CY2019Q1	cno	Other Comprehensive Income Loss Reclassification Adjustment For Amortization Of Present Value Of Future Profits And Deferred Acquisition Costs Related To Net Realized Investment Gains Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForAmortizationOfPresentValueOfFutureProfitsAndDeferredAcquisitionCostsRelatedToNetRealizedInvestmentGainsBeforeTax	200000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-991400000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	609500000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-214100000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	132300000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-777300000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	477200000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-798500000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	529000000.0	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	3370900000	USD
CY2019Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-3100000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	3367800000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	51800000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	477100000	USD
CY2019Q1	cno	Noncredit Component Of Impairment Losses On Fixed Maturities Available For Sale NoncreditComponentOfImpairmentLossesOnFixedMaturitiesAvailableForSale	100000	USD
CY2019Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	47000000.0	USD
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	16100000	USD
CY2019Q1	cno	Stock Based Compensation StockBasedCompensation	4200000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	3837900000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4677000000.0	USD
CY2020Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-17800000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest Adjusted Balance1 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1	4659200000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-21200000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-777300000	USD
CY2020Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	83000000.0	USD
CY2019Q1	us-gaap	Proceeds From Interest And Dividends Received ProceedsFromInterestAndDividendsReceived	272300000	USD
CY2020Q1	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	34400000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8300000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	16000000.0	USD
CY2020Q1	cno	Stock Based Compensation StockBasedCompensation	4100000	USD
CY2019Q1	us-gaap	Proceeds From Fees Received ProceedsFromFeesReceived	31800000	USD
CY2020Q1	cno	Insurance Policy Benefits InsurancePolicyBenefits	429200000	USD
CY2019Q1	cno	Insurance Policy Benefits InsurancePolicyBenefits	407700000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	20300000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	28900000	USD
CY2020Q1	cno	Policy Acquisition Costs PolicyAcquisitionCosts	68200000	USD
CY2019Q1	cno	Policy Acquisition Costs PolicyAcquisitionCosts	69600000	USD
CY2020Q1	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	250100000	USD
CY2019Q1	us-gaap	Payments For Other Operating Activities PaymentsForOtherOperatingActivities	241800000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1900000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-5000000.0	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	125700000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	142300000	USD
CY2020Q1	cno	Sales Of Investments SalesOfInvestments	417900000	USD
CY2019Q1	cno	Sales Of Investments SalesOfInvestments	1775500000	USD
CY2020Q1	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	595700000	USD
CY2019Q1	cno	Maturities And Redemptions Of Investments MaturitiesAndRedemptionsOfInvestments	516200000	USD
CY2020Q1	cno	Purchases Of Investments PurchasesOfInvestments	1178200000	USD
CY2019Q1	cno	Purchases Of Investments PurchasesOfInvestments	2406500000	USD
CY2020Q1	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	-6300000	USD
CY2019Q1	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	-700000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7300000	USD
CY2019Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	10600000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-178200000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-126100000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2700000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2800000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	88000000.0	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	44000000.0	USD
CY2020Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	16200000	USD
CY2019Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	16400000	USD
CY2020Q1	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	404800000	USD
CY2019Q1	us-gaap	Proceeds From Annuities And Investment Certificates ProceedsFromAnnuitiesAndInvestmentCertificates	420100000	USD
CY2020Q1	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	354000000.0	USD
CY2019Q1	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	342800000	USD
CY2020Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	0	USD
CY2019Q1	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	50000000.0	USD
CY2020Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	500000	USD
CY2019Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	50300000	USD
CY2020Q1	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	500000	USD
CY2019Q1	cno	Repayments Of Investment Borrowings Related To Variable Interest Entities RepaymentsOfInvestmentBorrowingsRelatedToVariableInterestEntities	900000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-51700000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18500000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-104200000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	34700000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	654700000	USD
CY2019Q1	cno	Other Investments Allowance For Credit Loss Period Increase Decrease OtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	0	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	656600000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	550500000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	691300000	USD
CY2020Q1	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	13950000000.0	USD
CY2020Q1	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	15164800000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5470200000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5214300000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19420200000	USD
CY2020Q1	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	0	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation Depreciation On Fixed Maturity Securities Available For Sale When Other Than Temporary Impairment Loss Was Recognized AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationDepreciationOnFixedMaturitySecuritiesAvailableForSaleWhenOtherThanTemporaryImpairmentLossWasRecognized	1100000	USD
CY2020Q1	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	0	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Gains Losses On All Other Investments AccumulatedOtherComprehensiveIncomeLossNetUnrealizedGainsLossesOnAllOtherInvestments	2095300000	USD
CY2020Q1	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses	957400000	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments Having No Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsHavingNoAllowanceForCreditLosses	0	USD
CY2020Q1	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses	-120800000	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Net Unrealized Appreciation On Investments With Allowance For Credit Losses AccumulatedOtherComprehensiveIncomeLossNetUnrealizedAppreciationOnInvestmentsWithAllowanceForCreditLosses	0	USD
CY2020Q1	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-3900000	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Present Value Of Future Profits AccumulatedOtherComprehensiveIncomeLossAdjustmentToPresentValueOfFutureProfits	-18900000	USD
CY2020Q1	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-71000000.0	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Adjustment To Deferred Policy Acquisition Costs AccumulatedOtherComprehensiveIncomeLossAdjustmentToDeferredPolicyAcquisitionCosts	-227900000	USD
CY2020Q1	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	0	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Adjustment To Insurance Liabilities Due To Unrealized Gains That Would Result In Premium Deficiency If Unrealized Gains Were Realized AccumulatedOtherComprehensiveIncomeAdjustmentToInsuranceLiabilitiesDueToUnrealizedGainsThatWouldResultInPremiumDeficiencyIfUnrealizedGainsWereRealized	-96500000	USD
CY2020Q1	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-166500000	USD
CY2019Q4	cno	Accumulated Other Comprehensive Income Loss Deferred Income Tax Liabilities AccumulatedOtherComprehensiveIncomeLossDeferredIncomeTaxLiabilities	-380600000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	595200000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1372500000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	305200000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	308800000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1061500000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1065600000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1371300000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1375200000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	11212000000.0	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	12415200000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	20379100000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	282200000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	286000000.0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	1082200000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1130800000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	1376600000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	1481700000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10908600000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	12583700000	USD
CY2019Q4	cno	Available For Sale Securities Debt Maturities Amortized Cost Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostExcludingStructuredSecurities	13649600000	USD
CY2019Q4	cno	Available For Sale Securities Debt Maturities Fair Value Excluding Structured Securities AvailableForSaleSecuritiesDebtMaturitiesFairValueExcludingStructuredSecurities	15482200000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	5529900000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5813000000.0	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19179500000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21295200000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	5620700000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	547100000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	215000000.0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	34400000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	5835700000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	581500000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	1262800000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	11400000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	341200000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	9700000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	1604000000.0	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	21100000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	2100000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	19200000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-1100000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	300000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleAllowanceForCreditLossSellBeforeRecovery	0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Recovery DebtSecuritiesAvailableForSaleAllowanceForCreditLossRecovery	0	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	19900000	USD
CY2020Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	5900000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6700000	USD
CY2020Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1600000	USD
CY2020Q1	cno	Other Investments Allowance For Credit Loss Period Increase Decrease OtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-29500000	USD
CY2020Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-115500000	USD
CY2019Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	16100000	USD
CY2020Q1	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-15700000	USD
CY2020Q1	cno	Variable Interest Entities Change In Allowance For Current Expected Credit Losses VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses	-27800000	USD
CY2020Q1	us-gaap	Increase Decrease In Debt Securities Trading IncreaseDecreaseInDebtSecuritiesTrading	-26800000	USD
CY2020Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-115500000	USD
CY2020Q1	cno	Debt Securities Available For Sale And Other Investments Allowance For Credit Loss Period Increase Decrease DebtSecuritiesAvailableForSaleAndOtherInvestmentsAllowanceForCreditLossPeriodIncreaseDecrease	-55400000	USD
CY2019Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	16100000	USD
CY2019Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2200000	USD
CY2020Q1	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	174300000	USD
CY2019Q1	cno	Available For Sale Securities Value Of Securities Sold AvailableForSaleSecuritiesValueOfSecuritiesSold	747400000	USD
CY2019Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	2200000	USD
CY2018Q4	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	200000	USD
CY2019Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment	0	USD
CY2019Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Securities Sold OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold	0	USD
CY2019Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Change In Status OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsChangeInStatus	0	USD
CY2019Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Additional Credit Losses OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsAdditionalCreditLosses	0	USD
CY2019Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Reductions Cash Flows OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsCashFlows	0	USD
CY2019Q1	us-gaap	Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	200000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-21200000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	51800000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	145829000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	160948000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1241000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145829000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	162189000	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	768000	shares
CY2019Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2020Q1	cno	Segment Revenues SegmentRevenues	817300000	USD
CY2019Q1	cno	Segment Revenues SegmentRevenues	984000000.0	USD
CY2020Q1	cno	Segment Expenses SegmentExpenses	711800000	USD
CY2019Q1	cno	Segment Expenses SegmentExpenses	900600000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	105500000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	83400000	USD
CY2020Q1	cno	Income Tax Benefit On Operating Income Loss IncomeTaxBenefitOnOperatingIncomeLoss	21200000	USD
CY2019Q1	cno	Income Tax Benefit On Operating Income Loss IncomeTaxBenefitOnOperatingIncomeLoss	17600000	USD
CY2020Q1	cno	Operating Income Loss Net Of Tax OperatingIncomeLossNetOfTax	84300000	USD
CY2019Q1	cno	Operating Income Loss Net Of Tax OperatingIncomeLossNetOfTax	65800000	USD
CY2020Q1	cno	Segment Revenues SegmentRevenues	817300000	USD
CY2019Q1	cno	Segment Revenues SegmentRevenues	984000000.0	USD
CY2020Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-115500000	USD
CY2019Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	16100000	USD
CY2020Q1	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	10700000	USD
CY2019Q1	cno	Revenues Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests RevenuesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	17900000	USD
CY2020Q1	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	4700000	USD
CY2019Q1	cno	Revenue Relatedto Transitionand Support Services Agreements RevenueRelatedtoTransitionandSupportServicesAgreements	5000000.0	USD
CY2020Q1	us-gaap	Revenues Revenues	717200000	USD
CY2019Q1	us-gaap	Revenues Revenues	1023000000.0	USD
CY2020Q1	cno	Segment Expenses SegmentExpenses	711800000	USD
CY2019Q1	cno	Segment Expenses SegmentExpenses	900600000	USD
CY2020Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-83800000	USD
CY2019Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-37400000	USD
CY2020Q1	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-17100000	USD
CY2019Q1	cno	Embedded Derivative Amortization Related To Fair Value Changes In Embedded Derivative Liabilities EmbeddedDerivativeAmortizationRelatedToFairValueChangesInEmbeddedDerivativeLiabilities	-7800000	USD
CY2020Q1	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	-3400000	USD
CY2019Q1	cno	Amortization Related To Investment Gains Losses AmortizationRelatedToInvestmentGainsLosses	200000	USD
CY2020Q1	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	11000000.0	USD
CY2019Q1	cno	Expenses Related To Certain Non Strategic Investments And Earnings Attributable To Non Controlling Interests ExpensesRelatedToCertainNonStrategicInvestmentsAndEarningsAttributableToNonControllingInterests	16900000	USD
CY2020Q1	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	0	USD
CY2019Q1	cno	Fair Value Compensation Plan Changesin Fair Value Gain Loss FairValueCompensationPlanChangesinFairValueGainLoss	-5300000	USD
CY2020Q1	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	2100000	USD
CY2019Q1	cno	Expensesrelatedtotransitionandsupportservicesagreements Expensesrelatedtotransitionandsupportservicesagreements	4800000	USD
CY2020Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	788200000	USD
CY2019Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	957400000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-71000000.0	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	65600000	USD
CY2020Q1	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	-15800000	USD
CY2019Q1	cno	Income Tax Expense Benefit Before Valuation Allowance Adjustment IncomeTaxExpenseBenefitBeforeValuationAllowanceAdjustment	13800000	USD
CY2020Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-34000000.0	USD
CY2019Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-21200000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	51800000	USD
CY2020Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Net EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet	115000000	USD
CY2020Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-63600000	USD
CY2019Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5200000	USD
CY2020Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-219400000	USD
CY2019Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	10000000.0	USD
CY2020Q1	us-gaap	Ceded Premiums Written CededPremiumsWritten	84000000.0	USD
CY2019Q1	us-gaap	Ceded Premiums Written CededPremiumsWritten	67900000	USD
CY2020Q1	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	106000000.0	USD
CY2019Q1	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	108700000	USD
CY2020Q1	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	6000000.0	USD
CY2019Q1	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	6500000	USD
CY2020Q1	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	8400000	USD
CY2019Q1	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	8900000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	47800000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	10300000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	346000000.0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities	351300000	USD
CY2020Q1	cno	Deferred Tax Assets Indirect Costs Allocableto Self Constructed Real Estate Assets DeferredTaxAssetsIndirectCostsAllocabletoSelfConstructedRealEstateAssets	51600000	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8600000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15800000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13800000	USD
CY2020Q1	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-34000000.0	USD
CY2019Q1	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	USD
CY2020Q1	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	-49800000	USD
CY2019Q1	cno	Income Tax Expense Benefit Total IncomeTaxExpenseBenefitTotal	13800000	USD
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.027
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.009
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.014
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.009
CY2020Q1	cno	Effective Income Tax Rate Reconciliation Before Discrete Items Percent EffectiveIncomeTaxRateReconciliationBeforeDiscreteItemsPercent	0.223
CY2019Q1	cno	Effective Income Tax Rate Reconciliation Before Discrete Items Percent EffectiveIncomeTaxRateReconciliationBeforeDiscreteItemsPercent	0.210
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.478
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.701
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.210
CY2020Q1	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-34000000.0	USD
CY2020Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	460300000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	532300000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	9100000	USD
CY2019Q4	cno	Deferred Tax Assets Indirect Costs Allocableto Self Constructed Real Estate Assets DeferredTaxAssetsIndirectCostsAllocabletoSelfConstructedRealEstateAssets	50300000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	55300000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	40400000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	922300000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	984600000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	7400000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	24400000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	149100000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	150100000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	165900000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other Comprehensive Income DeferredTaxLiabilitiesOtherComprehensiveIncome	381200000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	322400000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	555700000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	599900000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	428900000	USD
CY2020Q1	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	103300000	USD
CY2019Q4	cno	Prepaid Accrued Income Taxes Current PrepaidAccruedIncomeTaxesCurrent	3700000	USD
CY2020Q1	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	703200000	USD
CY2019Q4	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	432600000	USD
CY2020Q1	cno	Aggregate Growth Rateforthe Next Five Years Includedin Deferred Tax Valuation Analysis AggregateGrowthRatefortheNextFiveYearsIncludedinDeferredTaxValuationAnalysis	0.035
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	599900000	USD
CY2019Q4	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-193700000	USD
CY2020Q1	cno	Loss Limitation Based On Income Of Life Insurance Company LossLimitationBasedOnIncomeOfLifeInsuranceCompany	0.35
CY2020Q1	cno	Loss Limitation Based On Loss Of Non Life Entities LossLimitationBasedOnLossOfNonLifeEntities	0.35
CY2020Q1	cno	Federal Long Term Tax Exempt Rate FederalLongTermTaxExemptRate	0.0163
CY2020Q1	cno	Nonoperating Loss Carryforwards NonoperatingLossCarryforwards	2145500000	USD
CY2020Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2191700000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	9100000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	10300000	USD
CY2020Q1	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	10600000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	10900000	USD
CY2020Q1	us-gaap	Notes Payable NotesPayable	989400000	USD
CY2019Q4	us-gaap	Notes Payable NotesPayable	989100000	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2020Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1000000000.0	USD
CY2020Q1	us-gaap	Long Term Debt LongTermDebt	1000000000.0	USD
CY2020Q1	cno	Number Of Insurance Subsidiaries That Are Members Of The Federal Home Loan Bank NumberOfInsuranceSubsidiariesThatAreMembersOfTheFederalHomeLoanBank	3	subsidiary
CY2020Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	83000000.0	USD
CY2020Q1	cno	Stock Repurchase Program Remaining Repurchase Authorized Amount StockRepurchaseProgramRemainingRepurchaseAuthorizedAmount	449300000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	16000000.0	USD
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
CY2020Q1	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	3300000	USD
CY2019Q1	us-gaap	Deferred Sales Inducements Additions DeferredSalesInducementsAdditions	7100000	USD
CY2020Q1	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	-300000	USD
CY2019Q1	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	1500000	USD
CY2020Q1	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	64300000	USD
CY2019Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	60700000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21293100000	USD
CY2020Q1	us-gaap	Notes Receivable Net NotesReceivableNet	15654300000	USD
CY2020Q1	cno	Investments Held By Variable Interest Entities InvestmentsHeldByVariableInterestEntities	1178700000	USD
CY2020Q1	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	437500000	USD
CY2020Q1	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	4781700000	USD
CY2020Q1	us-gaap	Assets Assets	33613100000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	517900000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	4659200000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	18443700000	USD
CY2019Q1	cno	Deferred Income Tax Assets Net Including Netof Current Income Tax Payable DeferredIncomeTaxAssetsNetIncludingNetofCurrentIncomeTaxPayable	630900000	USD
CY2019Q1	us-gaap	Assets Assets	31436700000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	193500000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	3367800000	USD
CY2020Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION AND OTHER LEGAL PROCEEDINGS</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts. We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred. The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict. In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the future profitability of the related insurance policies. Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters. The Company reviews these matters on an ongoing basis. When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 19, 2018, Melanie Cyganowski, as Equity Receiver for Platinum Partners Credit Opportunities Master Fund, LP ("PPCO") and other Platinum entities (the "PPCO Receiver") brought an action in the United States District Court for the Southern District of New York, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cyganowski v. Beechwood Re Ltd, et al.</span><span style="font-family:inherit;font-size:10pt;">, alleging, among other claims, fraud, aiding and abetting fraud, fraudulent transfer and violation of the Racketeer Influenced and Corrupt Organizations Act against numerous defendants, including Beechwood Re Ltd. ("BRe") and many of its affiliates, CNO Financial Group, Inc., Bankers Conseco Life Insurance Company ("BCLIC"), Washington National and 40\|86 Advisors, Inc. The PPCO Receiver alleges that Platinum insiders conspired with BRe and its principals and affiliates in a massive fraudulent scheme to enrich the Platinum and BRe insiders to the detriment of Platinum investors and creditors. The PPCO Receiver alleges that CNO Financial Group, Inc., BCLIC, Washington National and 40\|86 Advisors, Inc. have liability for the fraudulent scheme of the Platinum and BRe insiders under a theory that they turned a blind eye to the fraudulent scheme due to their desire to transfer unprofitable legacy portfolios of long-term care insurance via the reinsurance transactions with BRe. On January 24, 2019, the court consolidated the PPCO Receiver action with </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> other cases (to which the CNO companies are not parties) before it for at least discovery purposes. On August 19, 2019, the court granted in their entirety CNO Financial Group, Inc.’s and 40\|86 Advisors, Inc.’s motions to dismiss the PPCO Receiver’s claims against them. The court granted in part and denied in part the motions to dismiss of BCLIC and Washington National, dismissing the PPCO Receiver’s claims for, among other things, fraud, aiding and abetting fraud, securities fraud and violation of the Racketeer Influenced and Corrupt Organizations Act, while denying BCLIC’s and Washington National’s motions to dismiss the PPCO Receiver’s fraudulent transfer and unjust enrichment claims. BCLIC and Washington National have agreed with the PPCO Receiver to fully settle the </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Cyganowski</span><span style="font-family:inherit;font-size:10pt;"> case and are preparing a settlement agreement for approval by the court. Under the settlement, neither BCLIC nor Washington National will incur any liability or make any payment to anyone, but instead they will be granted an allowed claim against PPCO’s estate.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On April 9, 2019, BCLIC and Washington National commenced an action entitled</span><span style="font-family:inherit;font-size:10pt;font-style:italic;"> Bankers Conseco Life Insurance Company and Washington National Insurance Company v. Wilmington Trust, National Association</span><span style="font-family:inherit;font-size:10pt;">, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "Wilmington Action"). In the Wilmington Action, BCLIC and Washington National assert claims against Wilmington Trust, National Association ("Wilmington") for breaching its express contractual obligations under four trust agreements pursuant to which Wilmington was the trustee in regard to trust assets ceded as part of reinsurance agreements with BRe, as well as for breaching its fiduciary duties to BCLIC and Washington National. The Court granted Wilmington’s motion to dismiss this litigation. BCLIC and Washington National are appealing the</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Court’s decision.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 7, 2019, the Joint Official Liquidators of Platinum Partners Value Arbitrage Fund L.P. (in Official Liquidation) and Principal Growth Strategies, LLC, commenced suit against, among others, BCLIC, Washington National, 40\|86 Advisors, Inc. and CNO Financial Group, Inc. (collectively, the "CNO Parties") in Delaware Chancery Court. Plaintiffs allege that the CNO Parties were unjustly enriched when they terminated BCLIC and Washington National's reinsurance agreements with BRe and recaptured assets from reinsurance trusts, in particular, Agera securities. Plaintiffs contend that the Agera securities </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">were fraudulently transferred to the Reinsurance Trusts by other Platinum-related entities and they are seeking to claw back those Agera securities, or the value of those assets, from the CNO Parties. The CNO Parties are vigorously contesting the</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">plaintiff’s claims. The CNO Parties had removed the case to the United States District Court for the District of Delaware but on April 6, 2020, the District Court granted the plaintiff's motion to remand the case back to the Delaware Chancery Court. </span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 28, 2019, BCLIC and Washington National commenced an action entitled Bankers Conseco Life Insurance Company and Washington National Insurance Company v. KPMG LLP, in the Supreme Court of the State of New York, County of New York, Commercial Division (the "KPMG Action"). In the KPMG Action, BCLIC and Washington National assert claims against KPMG LLP ("KPMG") for aiding and abetting fraud, constructive fraud and negligent misrepresentation arising from KPMG's alleged role in the Platinum Partners' scheme to defraud BCLIC and Washington National into reinsuring its long-term care business with BRe. The Court granted KPMG’s motion to dismiss this litigation. BCLIC and Washington</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">National are appealing the Court’s decision.</span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Regulatory Examinations and Fines</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Insurance companies face significant risks related to regulatory investigations and actions. Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers. We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities. The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty. In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries. Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File ("SSADMF") to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;"><span>41</span></span><span style="font-family:inherit;font-size:10pt;"> states and the District of Columbia participated in this examination. In November 2018, we entered into a Global Resolution Agreement for compliance with laws and regulations concerning the identification, reporting and escheatment of unclaimed contract benefits or abandoned funds. Under the terms of the Global Resolution Agreement, a third-party auditor acting on behalf of the signatory jurisdictions will compare expanded matching criteria to the SSADMF to identify deceased insureds and contract holders where a valid claim has not been made.</span></div>
CY2020Q1	cno	Number Of States Participating In Examination Of Compliance With Unclaimed Property Laws NumberOfStatesParticipatingInExaminationOfComplianceWithUnclaimedPropertyLaws	41	state
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-21200000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	51800000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	59600000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	66600000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-51700000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	18700000	USD
CY2020Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	9700000	USD
CY2019Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	177900000	USD
CY2020Q1	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	116100000	USD
CY2019Q1	cno	Change In Accrued Investment Income And Amortization Of Premium Or Discount On Investments ChangeInAccruedInvestmentIncomeAndAmortizationOfPremiumOrDiscountOnInvestments	-83600000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	68200000	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	69600000	USD
CY2020Q1	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	-115500000	USD
CY2019Q1	cno	Gain Losson Investments Excluding Cash Expenses GainLossonInvestmentsExcludingCashExpenses	16100000	USD
CY2020Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-34100000	USD
CY2019Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-3400000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	125700000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	142300000	USD
CY2020Q1	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	4600000	USD
CY2019Q1	cno	Share Based Compensation Noncash Portion ShareBasedCompensationNoncashPortion	4400000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	6200000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	6100000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	6300000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	6000000.0	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3200000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4300000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63900000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65500000	USD
CY2020Q1	cno	Variable Interest Entity Amortized Cost Securities Held VariableInterestEntityAmortizedCostSecuritiesHeld	1216400000	USD
CY2020Q1	cno	Variable Interest Entity Gross Unrealized Gains Fixed Maturity Securities VariableInterestEntityGrossUnrealizedGainsFixedMaturitySecurities	400000	USD
CY2020Q1	cno	Variable Interest Entity Gross Unrealized Losses Fixed Maturity Securities VariableInterestEntityGrossUnrealizedLossesFixedMaturitySecurities	141000000.0	USD
CY2020Q1	cno	Variable Interest Entity Fixed Maturity Securities Allowance For Credit Loss VariableInterestEntityFixedMaturitySecuritiesAllowanceForCreditLoss	37700000	USD
CY2020Q1	cno	Variable Interest Entity Fixed Maturity Securities Fair Value VariableInterestEntityFixedMaturitySecuritiesFairValue	1038100000	USD
CY2020Q1	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	30100000	USD
CY2020Q1	cno	Variable Interest Entities Net Gain Loss From Sale Of Fixed Maturity Investments VariableInterestEntitiesNetGainLossFromSaleOfFixedMaturityInvestments	2300000	USD
CY2020Q1	cno	Variable Interest Entities Change In Allowance For Current Expected Credit Losses VariableInterestEntitiesChangeInAllowanceForCurrentExpectedCreditLosses	-27800000	USD
CY2020Q1	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	2300000	USD
CY2020Q1	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	18500000	USD
CY2019Q1	cno	Variable Interest Entities Net Realized Gain Loss On Investments VariableInterestEntitiesNetRealizedGainLossOnInvestments	8200000	USD
CY2019Q1	cno	Variable Interest Entity Investments Gross Investment Losses From Sale Before Tax VariableInterestEntityInvestmentsGrossInvestmentLossesFromSaleBeforeTax	8500000	USD
CY2019Q1	cno	Variable Interest Entities Investments Sold VariableInterestEntitiesInvestmentsSold	249700000	USD
CY2020Q1	cno	Number Of Investments Held By Variable Interest Entities In Default NumberOfInvestmentsHeldByVariableInterestEntitiesInDefault	0	investment
CY2020Q1	cno	Investments Held In Limited Partnerships InvestmentsHeldInLimitedPartnerships	569800000	USD
CY2020Q1	cno	Unfunded Commitmentsto Limited Partnerships UnfundedCommitmentstoLimitedPartnerships	94800000	USD
CY2020Q1	cno	Fair Value Fixed Maturity Securities Valued Using Broker Quotes Percentage FairValueFixedMaturitySecuritiesValuedUsingBrokerQuotesPercentage	0.89
CY2020Q1	cno	Available For Sale Fixed Maturities With Significant Unobservable Inputs Investment Grade Percent AvailableForSaleFixedMaturitiesWithSignificantUnobservableInputsInvestmentGradePercent	0.95
CY2020Q1	cno	Available For Sale Maturities With Significant Unobservable Inputs Corporate Securities Percent AvailableForSaleMaturitiesWithSignificantUnobservableInputsCorporateSecuritiesPercent	0.77

Files In Submission

Name	View Source	Status
0001224608-20-000019-index-headers.html	Edgar Link	pending
0001224608-20-000019-index.html	Edgar Link	pending
0001224608-20-000019.txt	Edgar Link	pending
0001224608-20-000019-xbrl.zip	Edgar Link	pending
cno-20200331.xsd	Edgar Link	pending
cno-20200331_cal.xml	Edgar Link	unprocessable
cno-20200331_def.xml	Edgar Link	unprocessable
cno-20200331_lab.xml	Edgar Link	unprocessable
cno-20200331_pre.xml	Edgar Link	unprocessable
cno0331202010-q.htm	Edgar Link	pending
cno0331202010-q_htm.xml	Edgar Link	completed
cno03312020ex101.htm	Edgar Link	pending
cno03312020ex102.htm	Edgar Link	pending
cno03312020ex103.htm	Edgar Link	pending
cno03312020ex104.htm	Edgar Link	pending
cno03312020ex311.htm	Edgar Link	pending
cno03312020ex312.htm	Edgar Link	pending
cno03312020ex321.htm	Edgar Link	pending
cno03312020ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgchart2020.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNO
CNO Financial Group, Inc. Stock $cno

2020 Q1 Form 10-Q Financial Statement

#000122460820000019 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO CNO Financial Group, Inc. Stock $cno

2020 Q1 Form 10-Q Financial Statement

#000122460820000019 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNO
CNO Financial Group, Inc. Stock $cno